openPR Logo
Press release

Lisa C. Levine Named 2025 Lou Posner Scholarship Winner

04-23-2025 11:00 PM CET | Science & Education

Press release from: ABNewswire

Boston, MA - April 23, 2025 - Auctus Fund Management and the Lou Posner Scholarship Committee are pleased to announce Lisa C. Levine as the 2025 Lou Posner Scholarship recipient. Lisa is pursuing dual graduate degrees-a PhD in Public Affairs and an MBA-at the University of Nevada, Las Vegas (UNLV). She was selected for her exceptional academic achievements, commitment to public service, and insightful essay that impressed the selection panel with its depth and relevance to today's financial leadership landscape.

In her essay, Lisa described the modern finance manager as a "multifaceted leader" essential to organizational success. She emphasized the importance of reputation, ethics, transparency, and strategic insight, noting that today's finance professionals must go beyond managing budgets and compliance and be visionaries. "Understanding ways to reduce costs while increasing profit is a traditional role," she wrote, "but more importantly, they should also be able to offer analysis and ideas on growth and market capitalization, as well as risk reduction and debt strategy."

Lisa also highlighted the growing trend of finance managers rising to executive leadership roles, including the C-suite and philanthropic leadership positions, underscoring their central role in shaping corporate and social outcomes.

Supporting Academic Excellence

The Lou Posner Scholarship is an annual $1,000 award created to support students pursuing higher education in finance and related fields. Open to both undergraduate and graduate students enrolled in accredited academic programs, the scholarship recognizes individuals who exemplify academic excellence, ethical leadership, and a forward-thinking approach to financial innovation. The 2025 application cycle closed on October 30, 2024. The scholarship reflects the values and vision of Lou Posner, a respected leader in the financial industry and an active advocate for education, mentorship, and professional development.

Scholarships like the Lou Posner Scholarship are crucial in empowering students to pursue their academic and professional goals without the added burden of financial strain. For many graduate and undergraduate students, scholarships provide much-needed financial support and validation of their hard work, dedication, and future potential. These awards can make the difference in allowing students to focus on their studies, engage in leadership opportunities, participate in research or internships, and ultimately graduate with the skills and experience necessary to drive meaningful change in their communities and industries. By investing in students today, scholarships help build the foundation for a stronger, more ethical, and more innovative future across all sectors.

About Auctus Fund Management

Auctus Fund Management, LLC, is a forward-thinking investment firm committed to responsible growth and leadership development. The Firm supports programs that nurture the next generation of finance professionals, and the scholarship is one of several initiatives that exemplify its dedication to impact-driven leadership. Lou Posner remains deeply engaged in guiding the scholarship's mission and mentoring emerging financial minds.

"We are proud to award the 2025 scholarship to Lisa C. Levine," said Lou Posner, who is on the scholarship committee. "Her vision, academic rigor, and dedication to ethical leadership embody the qualities the scholarship was created to encourage. With the support of Lou Posner and Auctus Fund Management, we look forward to watching her career flourish."

Media Contact
Company Name: Auctus Fund
Contact Person: Allison Batson
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lisa-c-levine-named-2025-lou-posner-scholarship-winner]
Country: United States
Website: https://louposnerscholarship.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lisa C. Levine Named 2025 Lou Posner Scholarship Winner here

News-ID: 3984734 • Views:

More Releases from ABNewswire

Metastatic Prostate Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharma, Mark Stein, Novartis, Orion
Metastatic Prostate Cancer Market to Reach New Heights in Growth by 2034, DelveI …
The Key Metastatic Prostate Cancer Companies in the market include - Curium US LLC, Bayer, Hookipa Biotech GmbH, University Health Network, Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharmaceuticals, Mark Stein, Novartis, Orion Corporation, Janssen Research & Development, AstraZeneca, MedSIR, Aragon Pharmaceuticals, Janssen Research & Development, Telix Pharmaceuticals, Alliance Foundation Trials, Epizyme, Inc., Exelixis, and others. DelveInsight's "Metastatic Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an
Glaucoma Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Q BioMed, InMed Pharma, ONL Therapeutics, Mitotech, TheratOcular Biotek
Glaucoma Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Co …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Glaucoma pipeline constitutes 50+ key companies continuously working towards developing 50+ Glaucoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Glaucoma Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/glaucoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Glaucoma Market. The Glaucoma Pipeline report embraces in-depth commercial and clinical
Hearing Loss Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics, Akouos
Hearing Loss Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hearing Loss pipeline constitutes 32+ key companies continuously working towards developing 35+ Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Hearing Loss Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hearing Loss Market. The Hearing Loss Pipeline report
Ankylosing Spondylitis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, UCB Biopharma, Fresenius Kabi, Shanghai Henlius Biotech
Ankylosing Spondylitis Pipeline 2025: FDA Updates, Therapy Innovations, and Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ankylosing Spondylitis pipeline constitutes 20+ key companies continuously working towards developing 20+ Ankylosing Spondylitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Ankylosing Spondylitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Lou

Lou Gehrig's Disease Pipeline: 75+ Innovators Pioneering Breakthrough Therapies …
The Lou Gehrig's Disease market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Denali Therapeutics, AbbVie, Calico Life Sciences, and Clene Nanomedicine Biosciences. These industry pioneers are transforming treatment strategies and redefining the future of Lou Gehrig's Disease, bringing new hope to patients worldwide. DelveInsight's "Lou Gehrig's Disease Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Lou
Lou Gehrigs Disease Market Sluggish Growth Rate Foreseen by 2024-2031
The Lou Gehrigs Disease Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Amyotrophic lateral sclerosis (ALS) is a devastating disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and eventually paralysis. The symptoms of amyotrophic lateral sclerosis (ALS) vary from person to person but typically include muscle weakness, stiffness, twitching, difficulty speaking, swallowing, and
pTools Announces ‘LOU in a Box’ Solution
pTools today, 28th of April 2021, announced it has launched a new SaaS based offering to the Local Operating Unit (LOU) market and surrounding organisations. The new system will allow small and large LOUs to manage their LEI issuance and applications on a web-based SaaS model, while preserving their existing processes. The solution is also available to Banks, Validation Agents, and other organisations responsible for the management of large numbers
Lou Ann Goodrich Awarded a Solo Art Exhibition
Jupiter, FL, USA -- Light Space & Time Online Art Gallery is very pleased to announce Lou Ann Goodrich has been awarded a month-long solo art exhibition on their website. Lou Ann is a wildlife photographer living and creating in Oregon. Lou Ann's photography will be featured on the gallery's front page and in the "Solo Art Series" section of their website. Lou Ann will also be promoted extensively in press
Lou Lihou Brings Universality to his Maritime Experience
Lou Lihou's paintings reflect the vibrant energy of the sea. A professional diver, Lihou brings an impressionistic brushstroke to his largely romantic subjects. His part oil, part acrylic canvases reveal a love of the maritime world, displaying the lifestyle, vigor and hues which invite the viewer into the artist's own experience. Lihou has lived most of his adult life in the Caribbean, but his early years were spent in the Channel
Lou Sansevero Joins RE/MAX Alliance Group In Sarasota
SARASOTA, FLORIDA – Realtor Lou Sansevero has joined RE/MAX Alliance Group in the University Office. He has seven years of real estate experience, and was previously associated with Keller Williams Realty and Atchley International Realty. An East County specialist, Sansevero also focuses on first-time home buyers, second home buyers, relocation buyers, investors and new construction. He has lived in the area for eight years. “After seven years of selling real